A citation-based method for searching scientific literature

Evan R Hermann, Emily Chambers, Danielle N Davis, McKale R Montgomery, Dingbo Lin, Winyoo Chowanadisai. Front Genet 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Phenome-Wide Association Study Uncovers a Pathological Role of Coagulation Factor X during Acinetobacter baumannii Infection.
Jacob E Choby, Andrew J Monteith, Lauren E Himmel, Paris Margaritis, Jana K Shirey-Rice, Andrea Pruijssers, Rebecca N Jerome, Jill Pulley, Eric P Skaar. Infect Immun 2019
5
100

Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?
Sandra Brasil, Carlota Pascoal, Rita Francisco, Vanessa Dos Reis Ferreira, Paula A Videira, And Gonçalo Valadão. Genes (Basel) 2019
16
100

Computational drug repositioning for rare diseases in the era of precision medicine.
Brian Delavan, Ruth Roberts, Ruili Huang, Wenjun Bao, Weida Tong, Zhichao Liu. Drug Discov Today 2018
36
100

Machine and deep learning approaches for cancer drug repurposing.
Naiem T Issa, Vasileios Stathias, Stephan Schürer, Sivanesan Dakshanamurthy. Semin Cancer Biol 2021
16
100

Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medications.
Jeffery A Goldstein, Lisa A Bastarache, Joshua C Denny, Dan M Roden, Jill M Pulley, David M Aronoff. Pharmacol Res 2018
9
100

Exploiting machine learning for end-to-end drug discovery and development.
Sean Ekins, Ana C Puhl, Kimberley M Zorn, Thomas R Lane, Daniel P Russo, Jennifer J Klein, Anthony J Hickey, Alex M Clark. Nat Mater 2019
90
100

PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations.
Joshua C Denny, Marylyn D Ritchie, Melissa A Basford, Jill M Pulley, Lisa Bastarache, Kristin Brown-Gentry, Deede Wang, Dan R Masys, Dan M Roden, Dana C Crawford. Bioinformatics 2010
540
100

Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study.
Thomas A Werfel, Donna J Hicks, Bushra Rahman, Wendy E Bendeman, Matthew T Duvernay, Jae G Maeng, Heidi Hamm, Robert R Lavieri, Meghan M Joly, Jill M Pulley,[...]. Mol Cancer Ther 2020
1
100


Development of a large-scale de-identified DNA biobank to enable personalized medicine.
D M Roden, J M Pulley, M A Basford, G R Bernard, E W Clayton, J R Balser, D R Masys. Clin Pharmacol Ther 2008
538
100

Drug Repurposing for Rare Diseases.
Helen I Roessler, Nine V A M Knoers, Mieke M van Haelst, Gijs van Haaften. Trends Pharmacol Sci 2021
4
100

Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.
Jill M Pulley, Rebecca N Jerome, Martin L Ogletree, Gordon R Bernard, Robert R Lavieri, Nicole M Zaleski, Charles C Hong, Jana K Shirey-Rice, Carlos L Arteaga, Ingrid A Mayer,[...]. Target Oncol 2018
5
100

A Computational Framework for Genome-wide Characterization of the Human Disease Landscape.
Young-Suk Lee, Arjun Krishnan, Rose Oughtred, Jennifer Rust, Christie S Chang, Joseph Ryu, Vessela N Kristensen, Kara Dolinski, Chandra L Theesfeld, Olga G Troyanskaya. Cell Syst 2019
8
100

Classifying Promoters by Interpreting the Hidden Information of DNA Sequences via Deep Learning and Combination of Continuous FastText N-Grams.
Nguyen Quoc Khanh Le, Edward Kien Yee Yapp, N Nagasundaram, Hui-Yuan Yeh. Front Bioeng Biotechnol 2019
23
100


Systematically Prioritizing Candidates in Genome-Based Drug Repurposing.
Anup P Challa, Robert R Lavieri, Judith T Lewis, Nicole M Zaleski, Jana K Shirey-Rice, Paul A Harris, David M Aronoff, Jill M Pulley. Assay Drug Dev Technol 2019
2
100

The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.
B S McEwen, S Chattarji, D M Diamond, T M Jay, L P Reagan, P Svenningsson, E Fuchs. Mol Psychiatry 2010
147
100

Can you teach old drugs new tricks?
Nicola Nosengo. Nature 2016
233
100

Using artificial intelligence methods to speed up drug discovery.
Óscar Álvarez-Machancoses, Juan Luis Fernández-Martínez. Expert Opin Drug Discov 2019
10
100

Applications of artificial intelligence in drug development using real-world data.
Zhaoyi Chen, Xiong Liu, William Hogan, Elizabeth Shenkman, Jiang Bian. Drug Discov Today 2021
3
100

Phenome-wide association study in adult coeliac disease: role of HLA subtype.
Carolin V Schneider, Moritz Kleinjans, Malin Fromme, Kai Markus Schneider, Pavel Strnad. Aliment Pharmacol Ther 2021
2
100

Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
Jill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, Rebecca N Jerome, Nicole M Zaleski, David M Aronoff, Lisa Bastarache, Xinnan Niu, Kenneth J Holroyd, Dan M Roden,[...]. Assay Drug Dev Technol 2017
21
100

Drug therapy of post-stroke aphasia: a review of current evidence.
Marcelo L Berthier, Friedemann Pulvermüller, Guadalupe Dávila, Natalia García Casares, Antonio Gutiérrez. Neuropsychol Rev 2011
39
100

Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.
Rebecca N Jerome, Meghan Morrison Joly, Nan Kennedy, Jana K Shirey-Rice, Dan M Roden, Gordon R Bernard, Kenneth J Holroyd, Joshua C Denny, Jill M Pulley. Drug Saf 2020
3
100

DrugBank 5.0: a major update to the DrugBank database for 2018.
David S Wishart, Yannick D Feunang, An C Guo, Elvis J Lo, Ana Marcu, Jason R Grant, Tanvir Sajed, Daniel Johnson, Carin Li, Zinat Sayeeda,[...]. Nucleic Acids Res 2018
100

Machine learning on drug-specific data to predict small molecule teratogenicity.
Anup P Challa, Andrew L Beam, Min Shen, Tyler Peryea, Robert R Lavieri, Ethan S Lippmann, David M Aronoff. Reprod Toxicol 2020
3
100

Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
Jill M Pulley, Jillian P Rhoads, Rebecca N Jerome, Anup P Challa, Kevin B Erreger, Meghan M Joly, Robert R Lavieri, Kelly E Perry, Nicole M Zaleski, Jana K Shirey-Rice,[...]. Annu Rev Pharmacol Toxicol 2020
14
100

A Phenome-Wide Association Study (PheWAS) of COVID-19 Outcomes by Race Using the Electronic Health Records Data in Michigan Medicine.
Maxwell Salvatore, Tian Gu, Jasmine A Mack, Swaraaj Prabhu Sankar, Snehal Patil, Thomas S Valley, Karandeep Singh, Brahmajee K Nallamothu, Sachin Kheterpal, Lynda Lisabeth,[...]. J Clin Med 2021
3
100

Advocating for mutually beneficial access to shelved compounds.
Jill M Pulley, Rebecca N Jerome, Jana K Shirey-Rice, Nicole M Zaleski, Helen M Naylor, Andrea J Pruijssers, James C Jackson, Gordon R Bernard, Kenneth J Holroyd. Future Med Chem 2018
1
100

Drug repositioning for rare diseases: Knowledge-based success stories.
Daniel Scherman, Christine Fetro. Therapie 2020
6
100

XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma.
Nguyen Quoc Khanh Le, Duyen Thi Do, Fang-Ying Chiu, Edward Kien Yee Yapp, Hui-Yuan Yeh, Cheng-Yu Chen. J Pers Med 2020
20
100

Repositioning Drugs for Rare Immune Diseases: Hopes and Challenges for a Precision Medicine.
Erica Valencic, Alenka Smid, Ziga Jakopin, Alberto Tommasini, Irena Mlinaric-Rascan. Curr Med Chem 2018
5
100

Review of Drug Repositioning Approaches and Resources.
Hanqing Xue, Jie Li, Haozhe Xie, Yadong Wang. Int J Biol Sci 2018
141
100

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data.
Joshua C Denny, Lisa Bastarache, Marylyn D Ritchie, Robert J Carroll, Raquel Zink, Jonathan D Mosley, Julie R Field, Jill M Pulley, Andrea H Ramirez, Erica Bowton,[...]. Nat Biotechnol 2013
444
100

Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
Rohan Gupta, Devesh Srivastava, Mehar Sahu, Swati Tiwari, Rashmi K Ambasta, Pravir Kumar. Mol Divers 2021
9
100

A primer on applying AI synergistically with domain expertise to oncology.
Jason Kim, Rebecca Kusko, Benjamin Zeskind, Jenny Zhang, Renan Escalante-Chong. Biochim Biophys Acta Rev Cancer 2021
1
100

PheWAS-ME: a web-app for interactive exploration of multimorbidity patterns in PheWAS.
Nick Strayer, Jana K Shirey-Rice, Yu Shyr, Joshua C Denny, Jill M Pulley, Yaomin Xu. Bioinformatics 2021
1
100

Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.
Rebecca N Jerome, Jill M Pulley, Dan M Roden, Jana K Shirey-Rice, Lisa A Bastarache, Gordon R Bernard, Leeland B Ekstrom, William J Lancaster, Joshua C Denny. Drug Saf 2018
13
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.